Nasdaq:US$17.93 (+1.56) | HKEX:HK$28.00 (+2.82) | AIM:£2.59 (+0.2)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF